Effect of peptichemio on immunocompetent lymphocytes and responsive antigens.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001345:Autoradiography; D001402:B-Lymphocytes / Q000276:immunology; D002250:Carbon Radioisotopes; D003208:Concanavalin A / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D007104:Immune Adherence Reaction; D037102:Lectins / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects*; D008239:Lysine / Q000378:metabolism; D008934:Mitogens / Q000494:pharmacology; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014373:Tuberculin / Q000494:pharmacology
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D037102:Lectins; D008934:Mitogens; D009588:Nitrogen Mustard Compounds; D010455:Peptides; D014373:Tuberculin; D014316:Tritium; D003208:Concanavalin A; D007930:Leucine; D008239:Lysine; D013936:Thymidine